Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.

@article{Papakostas2008EfficacyOB,
  title={Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.},
  author={G. Papakostas and S. Stahl and A. Krishen and C. A. Seifert and V. Tucker and E. P. Goodale and M. Fava},
  journal={The Journal of clinical psychiatry},
  year={2008},
  volume={69 8},
  pages={
          1287-92
        }
}
  • G. Papakostas, S. Stahl, +4 authors M. Fava
  • Published 2008
  • Medicine, Psychology
  • The Journal of clinical psychiatry
    • OBJECTIVE The goal of this work was to compare the efficacy of the norepinephrine and dopamine reuptake inhibitor bupropion with the selective serotonin reuptake inhibitors (SSRIs) in the treatment of major depressive disorder with high levels of anxiety (anxious depression). METHOD Ten double-blind, randomized studies from 1991 through 2006 were combined (N = 2122). Anxious depression was defined as a 17-item Hamilton Rating Scale for Depression (HAM-D-17) anxiety-somatization factor score… CONTINUE READING
    View PDF
    87 Citations
    Highly Influencial Citations
    2
    Background Citations
    25
    Methods Citations
    5
    Results Citations
    5
    87 Citations
    Citation Type

    Citation Type

    The Role of Bupropion in the Management of Major Depressive Disorder
    Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline
    • B. Bandelow, M. Bauer, +4 authors H. Eriksson
    • Psychology, Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2014
    • 17
    Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder
    • 42
    Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    • 52
    Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
    • 3
    Agomelatine: efficacy at each phase of antidepressant treatment.
    • 25
    Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study
    • 9
    Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram
    • 30
    Agomelatine in the treatment of major depressive disorder
    • 130
    Bupropion in the treatment of major depressive disorder: a comparison with paroxetine

    References

    SHOWING 1-10 OF 42 REFERENCES
    Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.
    • 35
    Resolution of Sleepiness and Fatigue in Major Depressive Disorder: A Comparison of Bupropion and the Selective Serotonin Reuptake Inhibitors
    • 115
    Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    • 85
    Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    • 144
    Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.
    • 279
    Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    • 127
    Does pretreatment anxiety predict response to either bupropion SR or sertraline?
    • 27
    • Highly Influential
    Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    • 833
    • PDF
    Response in Relation to Baseline Anxiety Levels in Major Depressive Disorder Treated with Bupropion Sustained Release or Sertraline
    • 51
    • Highly Influential
    • PDF
    Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    • 102
    • PDF